Nicole Dale

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

Read Genomic Governance Ensures Equity at the Core of Drug Discovery
- Multiomics
- AI Drug Discovery
- Drug Discovery
- Rare Diseases
- AI & Machine Learning
- Translational Science and Biomarkers
- Pharma Policy
- Clinical Trial Strategy
- Biostatistics
- Decentralised Manufacturing
Genomic Governance Ensures Equity at the Core of Drug Discovery
Read FDA Registration for Drug Manufacturing Enters a New Era
- Decentralised Manufacturing
- Pharma Regulation
- Pharma Policy
- Pharma Supply Chains
- Quality
- Pharmaceutical Compliance
- AI Pharma
- Continuous Manufacturing
- Biologics
- Next-gen Modalities
- CMC
FDA Registration for Drug Manufacturing Enters a New Era
Read AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck
- Cell and Gene Therapy
- Next-gen Modalities
- Rare Diseases
- Orphan Drugs
- Pharma Supply Chains
- AI and Automation
- AI & Machine Learning
- Pharma Policy
- Pharmaceutical Compliance
- Quality
- Pharma Regulation
- Continuous Manufacturing
- Biologics
- Biotech
- Bioprocessing
AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck
Read 11 Clinical Trials Defining Pharmaceutical Strategy in 2026
- Clinical Trial Strategy
- Clinical Trial Design
- Clinical Trial Regulation
- Clinical Data
- Adaptive Clinical Trials
- Clinical Outcomes
- Rare Diseases
- Orphan Drugs
- Decentralised Clinical Trials
- Patient Centricity and Outcomes
- Patient Enrolment
- Neurological Disease
- Next-gen Modalities
- Cell and Gene Therapy
- Cardiometabolic Diseases
- Peptides and Obesity Treatments
- Ocular Diseases
- Translational Science and Biomarkers
- Infectious Diseases and Vaccines
- Immunology and Immunotherapy
- Small Molecules
11 Clinical Trials Defining Pharmaceutical Strategy in 2026